Photobiostimulation Devices Market Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)
Description
The global photobiostimulation devices market was valued at USD 10.50 Billion in 2024 driven by rising incidence of musculoskeletal disorders and technological advancements across the globe. The market is expected to grow at a CAGR of 9.10% during the forecast period 2025-2034 and attain a market value of USD 25.09 Billion by 2034.
Photobiostimulation Devices Market Overview
Photobiostimulation devices provide successful treatment for pain, tissue healing, and inflammation. These devices utilize light energy to activate cellular processes via photobiomodulation (PBM). Certain light frequencies focus on tissues, interacting with cell photoreceptors to improve healing, growth, and pain reduction. These non-invasive devices are utilized in medical and aesthetic fields to treat conditions such as chronic pain and skin disorders, utilizing light to enhance natural healing and overall wellness.
These devices play a key role in contemporary healthcare by providing non-invasive treatment options for a range of ailments. They offer relief from pain, promote faster healing, and decrease inflammation with no adverse reactions. By boosting cellular healing, they enhance speedier recuperation and enhance results for patients. These devices are highly prized in both clinical and consumer markets for their effectiveness.
Photobiostimulation Devices Market Growth Drivers
Rising Incidence of Musculoskeletal Disorders
The World Health Organization (WHO) 2022 report revealed that 1.71 billion people have musculoskeletal conditions. In 2023, a report published in The Lancet showed a 123.4% increase in musculoskeletal disorders cases from 1990 to 2020, reaching 494 million globally. Predictions suggest a 115% increase by 2050, totalling to an estimated 1060 million prevalent cases. With aging populations, sedentary lifestyles, and heightened levels of physical activity, musculoskeletal issues such as chronic pain, arthritis, and injuries are increasing globally. These circumstances lead to unease, incapacity, and a depletion in the standard of living. Photobiostimulation devices provide non-invasive and efficient treatments to reduce inflammation, enhance cellular repair, and relieve pain associated with these issues. Hence, their application in managing these conditions is on the rise.
Launch of Technologically Advanced Products to Meet Rising Photobiostimulation Devices Market Demand
Advancements such as precise light delivery systems, portable devices, and advanced user interfaces are transforming the market for photobiostimulation devices with technological advancements. In June 2024, RevelAi Health and Zimmer Biomet Holdings signed a multi-year co-marketing deal to promote artificial intelligence-powered solutions for orthopedic care. Zimmer Biomet agreed to market RevelAi Health's patient care management platform and other products. In addition, in January 2024, Lumaflex released Lumaflex Essential, an affordable red light therapy device that offers similar benefits as Lumaflex Body Pro but is designed for quick 10-minute treatments for various users.
Photobiostimulation Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growing Popularity in Sports Medicine
Photobiostimulation devices are becoming popular in the field of sports medicine because they can speed up healing, decrease inflammation, and improve athletic performance. Athletes commonly face injuries and muscle discomfort. These devices provide a non-intrusive remedy and support speedier tissue healing, enabling athletes to get back to action quicker and with reduced pain. As the sports industry's need for non-invasive therapies increases, photobiostimulation is gaining popularity as a favored approach for enhancing muscle recovery and performance in athletes and sports professionals.
Growth in Home Use Devices to Augment Photobiostimulation Devices Market Size
Consumer demand for convenient and cost-effective home photobiostimulation devices is increasing. These devices are simpler to operate and enable individuals to control pain, recover, and enhance skincare in their own homes. They also provide convenience in scheduling and comfort, making them perfect for individuals with chronic illnesses or hectic schedules.
Increased Focus on Pain Management
Healthcare systems around the globe are looking for efficient strategies to deal with chronic pain, increasing the need for non-drug therapies such as photobiostimulation devices. The rise in demand for alternative treatments, and reducing the use of opioids is driving the market expansion of photobiostimulation devices.
Increased Research and Clinical Trials to Boost Photobiostimulation Devices Market Value
There are several research initiatives focused on discovering new uses, improving treatment methods, and confirming effectiveness for various medical conditions. Clinical trials offer evidence to support implementation in healthcare settings, obtaining regulatory approvals, and setting evidence-based guidelines. Such studies improve comprehension of the mechanisms behind photobiostimulation, enhancing treatment strategies.
Photobiostimulation Devices Market Segmentation
The EMR’s report titled “Photobiostimulation Devices Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type
Segmentation Based on Device Type to Witness Substantial Growth
The market based on the type of devices is segmented into low-level laser therapy (LLLT) devices, light emitting diodes (LED) devices, infrared devices, ultraviolet (UV) devices, combination devices, and others. Low-level laser therapy (LLLT) devices are projected to dominate the market due to their capacity to stimulate cellular healing and minimize inflammation through targeted laser light wavelengths. They have shown to be successful in addressing issues such as chronic pain, injuries, and skin disorders. Progress in laser technology continues to enhance their capabilities, establishing them as the preferred option for photobiostimulation.
Photobiostimulation Devices Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America is expected to dominate the market due to its advanced healthcare infrastructure, extensive medical research, and significant healthcare spending. The United States leads the market with a robust healthcare system and widespread use of advanced technology. In the region, growth is further driven by innovation, leading manufacturers, and increasing consumer awareness.
Europe is also poised to have a significant market share with countries such as Germany, France, and the United Kingdom at the forefront. Sophisticated healthcare systems, high-quality medical services, and investments in research propel the growth of the market.
Leading Players in the Photobiostimulation Devices Market
The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as strategic initiatives by the leading players. The major companies in the market are as follows:
Bioflex Laser
Bioflex Laser develops laser therapy systems for pain treatment, aiming to accelerate healing and improve quality of life. The device treats soft tissue injuries, arthritis, repetitive stress injuries, tissue repair, and wound healing. Using Class 3b lasers with bicolour LEDs, Bioflex targets injured tissues and the circulatory system for faster healing, reduced pain, inflammation, and edema.
BioLight Technologies Llc
BioLight Technologies focuses on developing products for ophthalmic conditions including glaucoma, dry eye syndrome, and age-related macular degeneration. Its portfolio includes Eye-D, IOPtiMate, TeaRx, and OphRx. The company also offers the AURA PTL II Clinical System, a low-level laser therapy system that combines various wellness features. This portable system provides relief from pain, nerve issues, and allergy symptoms, making complex science easy for everyone to benefit from.
Erchonia Corporation
Erchonia specializes in developing cosmetic and medical laser equipment for various therapies, such as cold laser therapy, low-level laser therapy, liposuction, and breast augmentation. The company offers a range of laser devices for pain relief, body contouring, and other treatments with proven efficacy.
K-Laser USA Inc.
K-Laser produces and sells medical laser equipment globally, embodying Italian excellence. The company has a strong portfolio in products that treat osteoarthritic pain, neck, back, and hand pain, fibromyalgia, sports injuries, and scar sensitivity, among others.
Other players in the market are BioPhotas Inc., Koninklijke Philips N.V., LED Technologies Inc., NeoLight LLC, Theralase Technologies Inc., and Thor Photomedicine Ltd.
Key Questions Answered in the Photobiostimulation Devices Market Report
Photobiostimulation Devices Market Overview
Photobiostimulation devices provide successful treatment for pain, tissue healing, and inflammation. These devices utilize light energy to activate cellular processes via photobiomodulation (PBM). Certain light frequencies focus on tissues, interacting with cell photoreceptors to improve healing, growth, and pain reduction. These non-invasive devices are utilized in medical and aesthetic fields to treat conditions such as chronic pain and skin disorders, utilizing light to enhance natural healing and overall wellness.
These devices play a key role in contemporary healthcare by providing non-invasive treatment options for a range of ailments. They offer relief from pain, promote faster healing, and decrease inflammation with no adverse reactions. By boosting cellular healing, they enhance speedier recuperation and enhance results for patients. These devices are highly prized in both clinical and consumer markets for their effectiveness.
Photobiostimulation Devices Market Growth Drivers
Rising Incidence of Musculoskeletal Disorders
The World Health Organization (WHO) 2022 report revealed that 1.71 billion people have musculoskeletal conditions. In 2023, a report published in The Lancet showed a 123.4% increase in musculoskeletal disorders cases from 1990 to 2020, reaching 494 million globally. Predictions suggest a 115% increase by 2050, totalling to an estimated 1060 million prevalent cases. With aging populations, sedentary lifestyles, and heightened levels of physical activity, musculoskeletal issues such as chronic pain, arthritis, and injuries are increasing globally. These circumstances lead to unease, incapacity, and a depletion in the standard of living. Photobiostimulation devices provide non-invasive and efficient treatments to reduce inflammation, enhance cellular repair, and relieve pain associated with these issues. Hence, their application in managing these conditions is on the rise.
Launch of Technologically Advanced Products to Meet Rising Photobiostimulation Devices Market Demand
Advancements such as precise light delivery systems, portable devices, and advanced user interfaces are transforming the market for photobiostimulation devices with technological advancements. In June 2024, RevelAi Health and Zimmer Biomet Holdings signed a multi-year co-marketing deal to promote artificial intelligence-powered solutions for orthopedic care. Zimmer Biomet agreed to market RevelAi Health's patient care management platform and other products. In addition, in January 2024, Lumaflex released Lumaflex Essential, an affordable red light therapy device that offers similar benefits as Lumaflex Body Pro but is designed for quick 10-minute treatments for various users.
Photobiostimulation Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Growing Popularity in Sports Medicine
Photobiostimulation devices are becoming popular in the field of sports medicine because they can speed up healing, decrease inflammation, and improve athletic performance. Athletes commonly face injuries and muscle discomfort. These devices provide a non-intrusive remedy and support speedier tissue healing, enabling athletes to get back to action quicker and with reduced pain. As the sports industry's need for non-invasive therapies increases, photobiostimulation is gaining popularity as a favored approach for enhancing muscle recovery and performance in athletes and sports professionals.
Growth in Home Use Devices to Augment Photobiostimulation Devices Market Size
Consumer demand for convenient and cost-effective home photobiostimulation devices is increasing. These devices are simpler to operate and enable individuals to control pain, recover, and enhance skincare in their own homes. They also provide convenience in scheduling and comfort, making them perfect for individuals with chronic illnesses or hectic schedules.
Increased Focus on Pain Management
Healthcare systems around the globe are looking for efficient strategies to deal with chronic pain, increasing the need for non-drug therapies such as photobiostimulation devices. The rise in demand for alternative treatments, and reducing the use of opioids is driving the market expansion of photobiostimulation devices.
Increased Research and Clinical Trials to Boost Photobiostimulation Devices Market Value
There are several research initiatives focused on discovering new uses, improving treatment methods, and confirming effectiveness for various medical conditions. Clinical trials offer evidence to support implementation in healthcare settings, obtaining regulatory approvals, and setting evidence-based guidelines. Such studies improve comprehension of the mechanisms behind photobiostimulation, enhancing treatment strategies.
Photobiostimulation Devices Market Segmentation
The EMR’s report titled “Photobiostimulation Devices Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type
- Low-level Laser Therapy (LLLT) Devices
- Light Emitting Diodes (LED) Devices
- Infrared Devices
- Ultraviolet (UV) Devices
- Combination Devices
- Others
- Handheld Devices
- Wearable Devices
- Panel Devices
- Red Light Therapy
- Near-Infrared Therapy
- Blue Light Therapy
- Pain Management
- Skin Rejuvenation
- Wound Healing
- Hair Growth Stimulation
- Muscle Recovery
- Neurological Disorders
- Others
- Hospitals
- Dermatology Clinics
- Home Care Settings
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Segmentation Based on Device Type to Witness Substantial Growth
The market based on the type of devices is segmented into low-level laser therapy (LLLT) devices, light emitting diodes (LED) devices, infrared devices, ultraviolet (UV) devices, combination devices, and others. Low-level laser therapy (LLLT) devices are projected to dominate the market due to their capacity to stimulate cellular healing and minimize inflammation through targeted laser light wavelengths. They have shown to be successful in addressing issues such as chronic pain, injuries, and skin disorders. Progress in laser technology continues to enhance their capabilities, establishing them as the preferred option for photobiostimulation.
Photobiostimulation Devices Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America is expected to dominate the market due to its advanced healthcare infrastructure, extensive medical research, and significant healthcare spending. The United States leads the market with a robust healthcare system and widespread use of advanced technology. In the region, growth is further driven by innovation, leading manufacturers, and increasing consumer awareness.
Europe is also poised to have a significant market share with countries such as Germany, France, and the United Kingdom at the forefront. Sophisticated healthcare systems, high-quality medical services, and investments in research propel the growth of the market.
Leading Players in the Photobiostimulation Devices Market
The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as strategic initiatives by the leading players. The major companies in the market are as follows:
Bioflex Laser
Bioflex Laser develops laser therapy systems for pain treatment, aiming to accelerate healing and improve quality of life. The device treats soft tissue injuries, arthritis, repetitive stress injuries, tissue repair, and wound healing. Using Class 3b lasers with bicolour LEDs, Bioflex targets injured tissues and the circulatory system for faster healing, reduced pain, inflammation, and edema.
BioLight Technologies Llc
BioLight Technologies focuses on developing products for ophthalmic conditions including glaucoma, dry eye syndrome, and age-related macular degeneration. Its portfolio includes Eye-D, IOPtiMate, TeaRx, and OphRx. The company also offers the AURA PTL II Clinical System, a low-level laser therapy system that combines various wellness features. This portable system provides relief from pain, nerve issues, and allergy symptoms, making complex science easy for everyone to benefit from.
Erchonia Corporation
Erchonia specializes in developing cosmetic and medical laser equipment for various therapies, such as cold laser therapy, low-level laser therapy, liposuction, and breast augmentation. The company offers a range of laser devices for pain relief, body contouring, and other treatments with proven efficacy.
K-Laser USA Inc.
K-Laser produces and sells medical laser equipment globally, embodying Italian excellence. The company has a strong portfolio in products that treat osteoarthritic pain, neck, back, and hand pain, fibromyalgia, sports injuries, and scar sensitivity, among others.
Other players in the market are BioPhotas Inc., Koninklijke Philips N.V., LED Technologies Inc., NeoLight LLC, Theralase Technologies Inc., and Thor Photomedicine Ltd.
Key Questions Answered in the Photobiostimulation Devices Market Report
- What was the global photobiostimulation devices market value in 2024?
- What is the global photobiostimulation devices market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on device type?
- What is the market segmentation based on end user?
- What is the market breakup based on technology?
- What is market segmentation based on wavelength?
- What is market segmentation based on application?
- What are the major factors aiding the global photobiostimulation devices market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the global photobiostimulation devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Photobiostimulation Devices Market Overview
- 3.1 Global Photobiostimulation Devices Market Historical Value (2018-2024)
- 3.2 Global Photobiostimulation Devices Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Photobiostimulation Devices Market Landscape*
- 5.1 Global Photobiostimulation Devices: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Photobiostimulation Devices: Product Landscape
- 5.2.1 Analysis by Device Type
- 5.2.2 Analysis by Technology
- 5.2.3 Analysis by Wavelength
- 5.2.4 Analysis by Application
- 6 Global Photobiostimulation Devices Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Photobiostimulation Devices Market: Trade Data Analysis (HS Code: 9189099)
- 7.1 Major Exporting Countries
- 7.1.1 By Value
- 7.1.2 By Volume
- 7.2 Major Importing Countries
- 7.2.1 By Value
- 7.2.2 By Volume
- 8 Global Photobiostimulation Devices Market Segmentation (218-2034)
- 8.1 Global Photobiostimulation Devices Market (2018-2034) by Device Type
- 8.1.1 Market Overview
- 8.1.2 Low-level Laser Therapy (LLLT) Devices
- 8.1.3 Light Emitting Diodes (LED) Devices
- 8.1.4 Infrared Devices
- 8.1.5 Ultraviolet (UV) Devices
- 8.1.6 Combination Devices
- 8.1.7 Others
- 8.2 Global Photobiostimulation Devices Market (2018-2034) by Technology
- 8.2.1 Market Overview
- 8.2.2 Handheld Devices
- 8.2.3 Wearable Devices
- 8.2.4 Panel Devices
- 8.3 Global Photobiostimulation Devices Market (2018-2034) by Wavelength
- 8.3.1 Market Overview
- 8.3.2 Red Light Therapy
- 8.3.3 Near-Infrared Therapy
- 8.3.4 Blue Light Therapy
- 8.4 Global Photobiostimulation Devices Market (2018-2034) by Application
- 8.4.1 Market Overview
- 8.4.2 Pain Management
- 8.4.3 Skin Rejuvenation
- 8.4.4 Wound Healing
- 8.4.5 Hair Growth Stimulation
- 8.4.6 Muscle Recovery
- 8.4.7 Neurological Disorders
- 8.4.8 Others
- 8.5 Global Photobiostimulation Devices Market (2018-2034) by End User
- 8.5.1 Market Overview
- 8.5.2 Hospitals
- 8.5.3 Dermatology Clinics
- 8.5.4 Home Care Settings
- 8.5.5 Others
- 8.6 Global Photobiostimulation Devices Market (2018-2034) by Region
- 8.6.1 Market Overview
- 8.6.2 North America
- 8.6.3 Europe
- 8.6.4 Asia Pacific
- 8.6.5 Latin America
- 8.6.6 Middle East and Africa
- 9 North America Photobiostimulation Devices Market (218-2034)
- 9.1 North America Photobiostimulation Devices Market (2018-2034) by Device Type
- 9.1.1 Market Overview
- 9.1.2 Low-level Laser Therapy (LLLT) Devices
- 9.1.3 Light Emitting Diodes (LED) Devices
- 9.1.4 Infrared Devices
- 9.1.5 Ultraviolet (UV) Devices
- 9.1.6 Combination Devices
- 9.1.7 Others
- 9.2 North America Photobiostimulation Devices Market (2018-2034) by Technology
- 9.2.1 Market Overview
- 9.2.2 Handheld Devices
- 9.2.3 Wearable Devices
- 9.2.4 Panel Devices
- 9.3 North America Photobiostimulation Devices Market (2018-2034) by Wavelength
- 9.3.1 Market Overview
- 9.3.2 Red Light Therapy
- 9.3.3 Near-Infrared Therapy
- 9.3.4 Blue Light Therapy
- 9.4 North America Photobiostimulation Devices Market (2018-2034) by Application
- 9.4.1 Market Overview
- 9.4.2 Pain Management
- 9.4.3 Skin Rejuvenation
- 9.4.4 Wound Healing
- 9.4.5 Hair Growth Stimulation
- 9.4.6 Muscle Recovery
- 9.4.7 Neurological Disorders
- 9.4.8 Others
- 9.5 North America Photobiostimulation Devices Market (2018-2034) by End User
- 9.5.1 Market Overview
- 9.5.2 Hospitals
- 9.5.3 Dermatology Clinics
- 9.5.4 Home Care Settings
- 9.5.5 Others
- 9.6 North America Photobiostimulation Devices Market (2018-2034) by Country
- 9.6.1 United States of America
- 9.6.2 Canada
- 10 Europe Photobiostimulation Devices Market (218-2034)
- 10.1 Europe Photobiostimulation Devices Market (2018-2034) by Device Type
- 10.1.1 Market Overview
- 10.1.2 Low-level Laser Therapy (LLLT) Devices
- 10.1.3 Light Emitting Diodes (LED) Devices
- 10.1.4 Infrared Devices
- 10.1.5 Ultraviolet (UV) Devices
- 10.1.6 Combination Devices
- 10.1.7 Others
- 10.2 Europe Photobiostimulation Devices Market (2018-2034) by Technology
- 10.2.1 Market Overview
- 10.2.2 Handheld Devices
- 10.2.3 Wearable Devices
- 10.2.4 Panel Devices
- 10.3 Europe Photobiostimulation Devices Market (2018-2034) by Wavelength
- 10.3.1 Market Overview
- 10.3.2 Red Light Therapy
- 10.3.3 Near-Infrared Therapy
- 10.3.4 Blue Light Therapy
- 10.4 Europe Photobiostimulation Devices Market (2018-2034) by Application
- 10.4.1 Market Overview
- 10.4.2 Pain Management
- 10.4.3 Skin Rejuvenation
- 10.4.4 Wound Healing
- 10.4.5 Hair Growth Stimulation
- 10.4.6 Muscle Recovery
- 10.4.7 Neurological Disorders
- 10.4.8 Others
- 10.5 Europe Photobiostimulation Devices Market (2018-2034) by End User
- 10.5.1 Market Overview
- 10.5.2 Hospitals
- 10.5.3 Dermatology Clinics
- 10.5.4 Home Care Settings
- 10.5.5 Others
- 10.6 Europe Photobiostimulation Devices Market (2018-2034) by Country
- 10.6.1 United Kingdom
- 10.6.2 Germany
- 10.6.3 France
- 10.6.4 Italy
- 10.6.5 Others
- 11 Asia Pacific Photobiostimulation Devices Market (218-2034)
- 11.1 Asia Pacific Photobiostimulation Devices Market (2018-2034) by Device Type
- 11.1.1 Market Overview
- 11.1.2 Low-level Laser Therapy (LLLT) Devices
- 11.1.3 Light Emitting Diodes (LED) Devices
- 11.1.4 Infrared Devices
- 11.1.5 Ultraviolet (UV) Devices
- 11.1.6 Combination Devices
- 11.1.7 Others
- 11.2 Asia Pacific Photobiostimulation Devices Market (2018-2034) by Technology
- 11.2.1 Market Overview
- 11.2.2 Handheld Devices
- 11.2.3 Wearable Devices
- 11.2.4 Panel Devices
- 11.3 Asia Pacific Photobiostimulation Devices Market (2018-2034) by Wavelength
- 11.3.1 Market Overview
- 11.3.2 Red Light Therapy
- 11.3.3 Near-Infrared Therapy
- 11.3.4 Blue Light Therapy
- 11.4 Asia Pacific Photobiostimulation Devices Market (2018-2034) by Application
- 11.4.1 Market Overview
- 11.4.2 Pain Management
- 11.4.3 Skin Rejuvenation
- 11.4.4 Wound Healing
- 11.4.5 Hair Growth Stimulation
- 11.4.6 Muscle Recovery
- 11.4.7 Neurological Disorders
- 11.4.8 Others
- 11.5 Asia Pacific Photobiostimulation Devices Market (2018-2034) by End User
- 11.5.1 Market Overview
- 11.5.2 Hospitals
- 11.5.3 Dermatology Clinics
- 11.5.4 Home Care Settings
- 11.5.5 Others
- 11.6 Asia Pacific Photobiostimulation Devices Market (2018-2034) by Country
- 11.6.1 China
- 11.6.2 Japan
- 11.6.3 India
- 11.6.4 ASEAN
- 11.6.5 Australia
- 11.6.6 Others
- 12 Latin America Photobiostimulation Devices Market (218-2034)
- 12.1 Latin America Photobiostimulation Devices Market (2018-2034) by Device Type
- 12.1.1 Market Overview
- 12.1.2 Low-level Laser Therapy (LLLT) Devices
- 12.1.3 Light Emitting Diodes (LED) Devices
- 12.1.4 Infrared Devices
- 12.1.5 Ultraviolet (UV) Devices
- 12.1.6 Combination Devices
- 12.1.7 Others
- 12.2 Latin America Photobiostimulation Devices Market (2018-2034) by Technology
- 12.2.1 Market Overview
- 12.2.2 Handheld Devices
- 12.2.3 Wearable Devices
- 12.2.4 Panel Devices
- 12.3 Latin America Photobiostimulation Devices Market (2018-2034) by Wavelength
- 12.3.1 Market Overview
- 12.3.2 Red Light Therapy
- 12.3.3 Near-Infrared Therapy
- 12.3.4 Blue Light Therapy
- 12.4 Latin America Photobiostimulation Devices Market (2018-2034) by Application
- 12.4.1 Market Overview
- 12.4.2 Pain Management
- 12.4.3 Skin Rejuvenation
- 12.4.4 Wound Healing
- 12.4.5 Hair Growth Stimulation
- 12.4.6 Muscle Recovery
- 12.4.7 Neurological Disorders
- 12.4.8 Others
- 12.5 Latin America Photobiostimulation Devices Market (2018-2034) by End User
- 12.5.1 Market Overview
- 12.5.2 Hospitals
- 12.5.3 Dermatology Clinics
- 12.5.4 Home Care Settings
- 12.5.5 Others
- 12.6 Latin America Photobiostimulation Devices Market (2018-2034) by Country
- 12.6.1 Brazil
- 12.6.2 Argentina
- 12.6.3 Mexico
- 12.6.4 Others
- 13 Middle East and Africa Photobiostimulation Devices Market (218-2034)
- 13.1 Middle East and Africa Photobiostimulation Devices Market (2018-2034) by Device Type
- 13.1.1 Market Overview
- 13.1.2 Low-level Laser Therapy (LLLT) Devices
- 13.1.3 Light Emitting Diodes (LED) Devices
- 13.1.4 Infrared Devices
- 13.1.5 Ultraviolet (UV) Devices
- 13.1.6 Combination Devices
- 13.1.7 Others
- 13.2 Middle East and Africa Photobiostimulation Devices Market (2018-2034) by Technology
- 13.2.1 Market Overview
- 13.2.2 Handheld Devices
- 13.2.3 Wearable Devices
- 13.2.4 Panel Devices
- 13.3 Middle East and Africa Photobiostimulation Devices Market (2018-2034) by Wavelength
- 13.3.1 Market Overview
- 13.3.2 Red Light Therapy
- 13.3.3 Near-Infrared Therapy
- 13.3.4 Blue Light Therapy
- 13.4 Middle East and Africa Photobiostimulation Devices Market (2018-2034) by Application
- 13.4.1 Market Overview
- 13.4.2 Pain Management
- 13.4.3 Skin Rejuvenation
- 13.4.4 Wound Healing
- 13.4.5 Hair Growth Stimulation
- 13.4.6 Muscle Recovery
- 13.4.7 Neurological Disorders
- 13.4.8 Others
- 13.5 Middle East and Africa Photobiostimulation Devices Market (2018-2034) by End User
- 13.5.1 Market Overview
- 13.5.2 Hospitals
- 13.5.3 Dermatology Clinics
- 13.5.4 Home Care Settings
- 13.5.5 Others
- 13.6 Middle East and Africa Photobiostimulation Devices Market (2018-2034) by Country
- 13.6.1 Saudi Arabia
- 13.6.2 United Arab Emirates
- 13.6.3 Nigeria
- 13.6.4 South Africa
- 13.6.5 Others
- 14 Regulatory Framework
- 14.1 Regulatory Overview
- 14.2 US FDA
- 14.3 EU EMA
- 14.4 INDIA CDSCO
- 14.5 JAPAN PMDA
- 14.6 Others
- 15 Patent Analysis
- 15.1 Analysis by Type of Patent
- 15.2 Analysis by Publication Year
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Patent Age
- 15.5 Analysis by CPC Analysis
- 15.6 Analysis by Patent Valuation
- 15.7 Analysis by Key Players
- 16 Grants Analysis
- 16.1 Analysis by Year
- 16.2 Analysis by Amount Awarded
- 16.3 Analysis by Issuing Authority
- 16.4 Analysis by Grant Application
- 16.5 Analysis by Funding Institute
- 16.6 Analysis by NIH Departments
- 16.7 Analysis by Recipient Organization
- 17 Funding and Investment Analysis
- 17.1 Analysis by Funding Instances
- 17.2 Analysis by Type of Funding
- 17.3 Analysis by Funding Amount
- 17.4 Analysis by Leading Players
- 17.5 Analysis by Leading Investors
- 17.6 Analysis by Geography
- 18 Strategic Initiatives
- 18.1 Analysis by Partnership Instances
- 18.2 Analysis by Type of Partnership and Collaborations
- 18.3 Analysis by Joint Ventures
- 18.4 Analysis by Leading Players
- 18.5 Analysis by Geography
- 19 Supplier Landscape
- 19.1 Market Share Analysis, By Region (Top 5 Companies)
- 19.1.1 Market Share Analysis: Global
- 19.1.2 Market Share Analysis: North America
- 19.1.3 Market Share Analysis: Europe
- 19.1.4 Market Share Analysis: Asia Pacific
- 19.1.5 Market Share Analysis: Others
- 19.2 Koninklijke Philips N.V.
- 19.2.1 Financial Analysis
- 19.2.2 Product Portfolio
- 19.2.3 Demographic Reach and Achievements
- 19.2.4 Company News and Development
- 19.2.5 Certifications
- 19.3 THOR Photomedicine Ltd
- 19.3.1 Financial Analysis
- 19.3.2 Product Portfolio
- 19.3.3 Demographic Reach and Achievements
- 19.3.4 Company News and Development
- 19.3.5 Certifications
- 19.4 Bioflex Laser
- 19.4.1 Financial Analysis
- 19.4.2 Product Portfolio
- 19.4.3 Demographic Reach and Achievements
- 19.4.4 Company News and Development
- 19.4.5 Certifications
- 19.5 BioLight Technologies LLC.
- 19.5.1 Financial Analysis
- 19.5.2 Product Portfolio
- 19.5.3 Demographic Reach and Achievements
- 19.5.4 Company News and Development
- 19.5.5 Certifications
- 19.6 BioPhotas Inc.
- 19.6.1 Financial Analysis
- 19.6.2 Product Portfolio
- 19.6.3 Demographic Reach and Achievements
- 19.6.4 Company News and Development
- 19.6.5 Certifications
- 19.7 K-Laser USA, Inc.
- 19.7.1 Financial Analysis
- 19.7.2 Product Portfolio
- 19.7.3 Demographic Reach and Achievements
- 19.7.4 Company News and Development
- 19.7.5 Certifications
- 19.8 NeoLight LLC
- 19.8.1 Financial Analysis
- 19.8.2 Product Portfolio
- 19.8.3 Demographic Reach and Achievements
- 19.8.4 Company New s and Development
- 19.8.5 Certifications
- 19.9 LED Technologies, Inc.
- 19.9.1 Financial Analysis
- 19.9.2 Product Portfolio
- 19.9.3 Demographic Reach and Achievements
- 19.9.4 Company News and Development
- 19.9.5 Certifications
- 19.10 Theralase Technologies Inc.
- 19.10.1 Financial Analysis
- 19.10.2 Product Portfolio
- 19.10.3 Demographic Reach and Achievements
- 19.10.4 Company News and Development
- 19.10.5 Certifications
- 19.11 Erchonia Corporation
- 19.11.1 Financial Analysis
- 19.11.2 Product Portfolio
- 19.11.3 Demographic Reach and Achievements
- 19.11.4 Company News and Development
- 19.11.5 Certifications
- 20 Global Photobiostimulation Devices Market – Distribution Model (Additional Insight)
- 20.1 Overview
- 20.2 Potential Distributors
- 20.3 Key Parameters for Distribution Partner Assessment
- 21 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
